IMPACT OF CIED INFECTIONS TYRX Absorbable Antibacterial Envelope
Despite efforts to take pacemaker precautions and reduce pacemaker risks, infection after cardiac implantable electronic defibrillators (CIEDs) implantation is a real possibility. When pacemaker infection does occur, the risk to the patient and the costs to the healthcare system are substantial.1-3
Infections typically cost the facility an average of ~$52,0004 but may exceed well over $100,000.3
Mortality significantly increased following CIED infections. Studies show a ~50% mortality rate at three years in patients who had a CIED infection.1
An infection may cost a facility $52,000 on
CIED infection rates affect Centers for Medicaid and Medicare Services (CMS) reimbursement.4 As of October 1, 2012, the CMS has reduced payments to hospitals when a patient undergoing a CIED procedure acquires an infection during their hospital stay.4
The TYRX™ Absorbable Antibacterial Envelope may help reduce infection; studies show a 70% to 100% reduction of infection in high-risk patients.
Mittal S et al. Heart Rhythm. 2014;11(4):595-601.
Henrikson CA et al. JACC EP.2017;3(10):1158-1167.
Sohail MR et al. Arch Intern Med. 2011;171(20):1821-1828.
Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services Inpatient Prospective Payment System (IPPS) Final Rule FY13.